EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 -0.0685
March 31, 2026 -0.1165
December 31, 2025 0.0501
September 30, 2025 -0.0906
June 30, 2025 -0.0879
March 31, 2025 -0.0688
December 31, 2024 -0.091
September 30, 2024 -0.0725
June 30, 2024 -0.1228
March 31, 2024 -0.2658
December 31, 2023 -0.248
September 30, 2023 -0.2653
June 30, 2023 -0.2166
March 31, 2023 -0.213
December 31, 2022 -0.2624
September 30, 2022 -0.373
June 30, 2022 -0.8165
March 31, 2022 -0.9904
December 31, 2021 -0.123
September 30, 2021 -0.1814
June 30, 2021 -0.2272
March 31, 2021 -0.2519
December 31, 2020 -0.2427
September 30, 2020 -0.0828
June 30, 2020 -0.1835
Date Value
March 31, 2020 -0.2268
December 31, 2019 -0.182
September 30, 2019 -0.1855
June 30, 2019 -0.1989
March 31, 2019 -0.436
December 31, 2018 -0.3561
September 30, 2018 -0.3759
June 30, 2018 -0.42
March 31, 2018 -0.34
December 31, 2017 -0.27
September 30, 2017 -0.46
June 30, 2017 -0.58
March 31, 2017 -0.59
December 31, 2016 -0.61
September 30, 2016 -0.68
June 30, 2016 -0.64
March 31, 2016 -0.69
December 31, 2015 -0.45
September 30, 2015 -0.32
June 30, 2015 -0.53
March 31, 2015 -0.56
December 31, 2014 -0.39
September 30, 2014 -0.49
June 30, 2014 -0.45
March 31, 2014 -0.57

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Illumina, Inc. 1.353
Agilent Technologies, Inc. 1.279
Bio-Rad Laboratories, Inc. 13.85
Bruker Corp. -0.413
Danaher Corp. 1.747